日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparison of stereotactic photon and proton treatment plans for metastasis-directed radiotherapy

转移灶定向放射治疗中立体定向光子和质子治疗方案的比较

Kato, Rans; Robin, De Roover; Gert, De Meerleer; Karin, Haustermans; Charlien, Berghen; Kenneth, Poels

Stereotactic Body Radiotherapy for Extracranial Oligometastatic Renal Cell Carcinoma: State of the Art and Future Perspectives

立体定向放射治疗颅外寡转移性肾细胞癌:现状与展望

Vandaele, Sander; Albersen, Maarten; Beuselinck, Benoit; Goffin, Karolien; Vandecaveye, Vincent; Vandermeulen, Henri; Berghen, Charlien

Citizen scientists: Unveiling motivations and characteristics influencing initial and sustained participation in an agricultural project

公民科学家:揭示影响其最初和持续参与农业项目的动机和特征

Vanden Berghen, Birgit; Vanermen, Iris; Vranken, Liesbet

The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects

大豆异黄酮在治疗前列腺癌中的应用:聚焦其细胞效应

Van der Eecken, Hans; Joniau, Steven; Berghen, Charlien; Rans, Kato; De Meerleer, Gert

Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study

前列腺局部放疗与全盆腔放疗的剂量学和血液学意义:多中心3期PROPER研究结果

Fonteyne, Valérie; Danckaert, Willeke; Ost, Piet; Berghen, Charlien; Vandecasteele, Katrien; Vanneste, Ben; Rans, Kato; Liefhooghe, Nick; Wallaert, Steven; Paelinck, Leen

SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?

SPARKLE:治疗寡复发性前列腺癌的新曙光:在立体定向放射治疗或转移瘤切除术中加入全身治疗:是实现长期无事件生存的关键吗?

Rans, Kato; Charlien, Berghen; Filip, Ameye; Olivier, De Hertogh; Julie, den Hartog; Céderic, Draulans; Herlinde, Dumez; Benedikt, Engels; Karolien, Goffin; Annouschka, Laenen; Nick, Liefhooghe; Kenneth, Poels; Carl, Salembier; Koen, Slabbaert; Hans, Vandendriessche; Ben, Vanneste; Steven, Joniau; Gert, De Meerleer

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial

评估 18F-FDG-PET-CT 对肌层浸润性膀胱癌患者风险分层和治疗方案调整的影响(EFFORT-MIBC):一项 II 期前瞻性试验

Verghote, Flor; Poppe, Lindsay; Verbeke, Sofie; Dirix, Piet; Albersen, Maarten; De Meerleer, Gert; Berghen, Charlien; Ost, Piet; Villeirs, Geert; De Visschere, Pieter; De Man, Kathia; De Maeseneer, Daan; Rottey, Sylvie; Van Praet, Charles; Decaestecker, Karel; Fonteyne, Valérie

Parameters predicting [(18)F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

预测前列腺癌生化复发患者[(18)F]PSMA-1007扫描阳性率以及检测到的病灶类型和数量的参数

Ahmadi Bidakhvidi, Niloefar; Laenen, Annouschka; Jentjens, Sander; Deroose, Christophe M; Van Laere, Koen; De Wever, Liesbeth; Mai, Cindy; Berghen, Charlien; De Meerleer, Gert; Haustermans, Karin; Joniau, Steven; Everaerts, Wouter; Goffin, Karolien

Longitudinal micro-computed tomography-derived biomarkers quantify non-resolving lung fibrosis in a silicosis mouse model

纵向微型计算机断层扫描衍生的生物标志物量化了矽肺小鼠模型中的非溶解性肺纤维化

Kaat Dekoster, Tatjana Decaesteker, Nathalie Berghen, Sofie Van den Broucke, Anne-Charlotte Jonckheere, Jens Wouters, Anton Krouglov, Rik Lories, Ellen De Langhe, Peter Hoet, Erik Verbeken, Jeroen Vanoirbeek #, Greetje Vande Velde #

Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial

针对去势抵抗性前列腺癌转移灶的治疗(MEDCARE):一项非随机 II 期试验

Berghen, Charlien; Joniau, Steven; Rans, Kato; Devos, Gaëtan; Poels, Kenneth; Slabbaert, Koen; Dumez, Herlinde; Albersen, Maarten; Goffin, Karolien; Haustermans, Karin; De Meerleer, Gert